NEGRINI, Federico
 Distribuzione geografica
Continente #
NA - Nord America 193
EU - Europa 59
AS - Asia 36
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 290
Nazione #
US - Stati Uniti d'America 184
CN - Cina 18
UA - Ucraina 15
GB - Regno Unito 10
CA - Canada 9
DE - Germania 7
IT - Italia 7
FI - Finlandia 6
HK - Hong Kong 6
TR - Turchia 6
BE - Belgio 5
FR - Francia 4
IE - Irlanda 4
SG - Singapore 3
IN - India 2
EU - Europa 1
IL - Israele 1
IM - Isola di Man 1
MU - Mauritius 1
Totale 290
Città #
Ann Arbor 27
Woodbridge 19
Ashburn 15
Chandler 14
Houston 14
Fairfield 13
Jacksonville 12
Ottawa 9
Cambridge 8
Nanjing 8
Wilmington 8
Princeton 7
Helsinki 6
Hong Kong 6
Kocaeli 6
New York 6
Seattle 6
Brussels 5
Auburn Hills 4
Dearborn 4
Dublin 4
Acton 2
Bellante 2
Des Moines 2
Jiaxing 2
Kunming 2
London 2
Los Angeles 2
San Mateo 2
Shenyang 2
Bergamo 1
Brescia 1
Douglas 1
Guangzhou 1
La Canada Flintridge 1
Nanchang 1
New Delhi 1
Oklahoma City 1
Pavia 1
Quzhou 1
Rezzato 1
San Diego 1
Singapore 1
Taizhou 1
Totale 233
Nome #
Long-term Picotamide, a dual thromboxane inhibitor, decreases urinary albumin excreation rate in type 2 diabetic patients with microalbuminuria at rest. 113
Long-term Picotamide, a dual thromboxane inhibitor, decreases both the urinary excretion of thromboxane B2 (TXB2) and albumin in patients with type 2 diabetes. 89
Is paracetamol better than placebo for knee and hip osteoarthritis? A Cochrane review summary with commentary 76
Robot‐assisted gait training in patients with multiple sclerosis: A randomized controlled crossover trial 22
Totale 300
Categoria #
all - tutte 1.632
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.632


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202040 0 0 0 2 2 6 7 7 4 5 4 3
2020/202189 4 7 2 3 21 23 0 6 5 9 7 2
2021/202238 2 4 0 3 2 3 0 6 3 4 4 7
2022/202342 4 2 0 2 6 12 0 3 7 0 1 5
2023/202427 2 1 0 9 0 6 0 0 6 0 0 3
2024/20251 0 1 0 0 0 0 0 0 0 0 0 0
Totale 300